| scholarly article | Q13442814 |
| P50 | author | Zhiming Song | Q59690562 |
| P2093 | author name string | Juanjuan Wang | |
| Yun-Zheng Le | |||
| Yanyan Bai | |||
| Meili Zhu | |||
| Daniel W Gil | |||
| Edwin Padillo | |||
| Jyotirmoy Kusari | |||
| Sheila X Zhou | |||
| P2860 | cites work | Interleukin 6 induces the expression of vascular endothelial growth factor | Q24316308 |
| Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid | Q29617640 | ||
| Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis | Q29617644 | ||
| VEGF is major stimulator in model of choroidal neovascularization. | Q30914479 | ||
| Foveolar choroidal blood flow in age-related macular degeneration. | Q32111311 | ||
| Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy. | Q33264002 | ||
| A novel imaging technique for experimental choroidal neovascularization | Q33264433 | ||
| Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization | Q33394749 | ||
| Oxidative damage and age-related macular degeneration | Q33774187 | ||
| Retinal and choroidal neovascularization | Q33980639 | ||
| Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. | Q34062411 | ||
| Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage | Q34082890 | ||
| Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization | Q34749337 | ||
| Role of alpha-2 agonists in neuroprotection | Q35174036 | ||
| Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization | Q35745444 | ||
| Erythropoietin deficiency decreases vascular stability in mice. | Q36404124 | ||
| Vascular endothelial growth factor expression in choroidal neovascularization in rats | Q36864325 | ||
| Inhibition of retinal neovascularization by siRNA targeting VEGF(165) | Q36957634 | ||
| Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration | Q37294413 | ||
| Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy | Q37607034 | ||
| Introduction: Understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration | Q37607656 | ||
| Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats | Q42520811 | ||
| Müller cell-derived VEGF is a significant contributor to retinal neovascularization | Q43273707 | ||
| Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine | Q43285278 | ||
| alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia | Q43512831 | ||
| Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death | Q43693068 | ||
| Brimonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death. | Q43760623 | ||
| Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. | Q44329008 | ||
| Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model. | Q45969448 | ||
| Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity | Q46097757 | ||
| Descending doses of intravitreal bevacizumab for the regression of diabetic neovascularization. | Q46167343 | ||
| Time-course of experimental choroidal neovascularization in Dutch-Belted rabbit: clinical and histological evaluation | Q46675298 | ||
| Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: neuroprotection with brimonidine | Q46722468 | ||
| Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model. | Q50923300 | ||
| The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas | Q71013356 | ||
| Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor | Q71402232 | ||
| Oxygen-induced retinopathy in the mouse | Q71608431 | ||
| Retinopathy of prematurity: recent advances in our understanding | Q74649816 | ||
| From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury | Q77407174 | ||
| The rationale for drug combinations in age-related macular degeneration | Q84123394 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neovascularization | Q1281049 |
| retinopathy of prematurity | Q1423087 | ||
| P304 | page(s) | 5424-5431 | |
| P577 | publication date | 2011-07-20 | |
| P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
| P1476 | title | Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats | |
| P478 | volume | 52 |
| Q84120622 | 17-Alpha-estradiol ameliorating oxygen-induced retinopathy in a murine model |
| Q34612126 | A novel in vivo model of focal light emitting diode-induced cone-photoreceptor phototoxicity: neuroprotection afforded by brimonidine, BDNF, PEDF or bFGF. |
| Q90379236 | Collagen peptide modified carboxymethyl cellulose as both antioxidant drug and carrier for drug delivery against retinal ischaemia/reperfusion injury |
| Q38885566 | Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics |
| Q42576282 | Minocycline modulates microglia polarization in ischemia-reperfusion model of retinal degeneration and induces neuroprotection |
| Q42151817 | Overexpression of Heme Oxygenase-1 in Mesenchymal Stem Cells Augments Their Protection on Retinal Cells In Vitro and Attenuates Retinal Ischemia/Reperfusion Injury In Vivo against Oxidative Stress |
| Q84789929 | Peptidoglycan and muramyl dipeptide from Staphylococcus aureus induce the expression of VEGF-A in human limbal fibroblasts with the participation of TLR2-NFκB and NOD2-EGFR |
| Q38644369 | Pomegranate protective effect on experimental ischemia/reperfusion retinal injury in rats (histological and biochemical study). |
| Q49381318 | Safety threshold of intravitreal clonidine in rabbit's eyes. |
| Q35484906 | Sulforaphane protects rodent retinas against ischemia-reperfusion injury through the activation of the Nrf2/HO-1 antioxidant pathway |
| Q37980016 | The emerging role of stem cells in ocular neurodegeneration: hype or hope? |
| Q92342987 | Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity |
| Q92277510 | Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS) |
Search more.